Genetic Susceptibility to Breast Cancer in Sub-Saharan African Populations
暂无分享,去创建一个
C. Mathew | Jean-tristan Brandenburg | W. Chen | Chantal Babb de Villiers | Mahtaab Hayat | Michéle Ramsay
[1] Jaana M. Hartikainen,et al. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. , 2021, The New England journal of medicine.
[2] Anisah W. Ghoorah,et al. High-depth African genomes inform human migration and health , 2020, Nature.
[3] F. Couch,et al. Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women. , 2020, Journal of the National Cancer Institute.
[4] M. Kotze,et al. Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing , 2020, Frontiers in Genetics.
[5] P. Sung,et al. The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication , 2020, Nature Reviews Molecular Cell Biology.
[6] A. Dem,et al. Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal , 2020, npj Genomic Medicine.
[7] O. Olopade,et al. Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon , 2019, Cancer Epidemiology, Biomarkers & Prevention.
[8] Dan J Stein,et al. Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017. , 2019, The Lancet. Global health.
[9] T. Ngoma,et al. Cancer control in Africa: is cancer research a luxury or necessity? , 2019, Ecancermedicalscience.
[10] Martha H Thomas,et al. Beyond BRCA: Review of Hereditary Syndromes Predisposing to Breast Cancer. , 2019, Journal of breast imaging.
[11] F. Couch,et al. Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future. , 2019, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[12] A. Dem,et al. Novel BRCA2 pathogenic variant c.5219 T > G; p.(Leu1740Ter) in a consanguineous Senegalese family with hereditary breast cancer , 2019, BMC Medical Genetics.
[13] M. Ostacher,et al. How genome-wide association studies (GWAS) made traditional candidate gene studies obsolete , 2019, Neuropsychopharmacology.
[14] H. Salehiniya,et al. Epidemiological characteristics of and risk factors for breast cancer in the world , 2019, Breast cancer.
[15] Scott M. Williams,et al. The Missing Diversity in Human Genetic Studies , 2019, Cell.
[16] C. Lewis,et al. Association of genetic variants in CHEK2 with oesophageal squamous cell carcinoma in the South African Black population , 2019, Carcinogenesis.
[17] A. Aseffa,et al. Vitamin D Status and Association of VDR Genetic Polymorphism to Risk of Breast Cancer in Ethiopia , 2019, Nutrients.
[18] E. Bonora,et al. Identification of BRCA1/2 p.Ser1613Gly, p.Pro871Leu, p.Lys1183Arg, p.Glu1038Gly, p.Ser1140Gly, p.Ala2466Val, p.His2440Arg variants in women under 45 years old with breast nodules suspected of having breast cancer in Burkina Faso , 2019, Biomolecular concepts.
[19] A. A. Zouré,et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) variants and breast cancer risk in Burkina Faso , 2019, Biomolecular concepts.
[20] D M Parkin,et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.
[21] Zachary Munn,et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach , 2018, BMC Medical Research Methodology.
[22] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[23] T. Walsh,et al. Inherited Breast Cancer in Nigerian Women , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] M. Mzibri,et al. BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso , 2018, Journal of public health in Africa.
[25] Y. Bakri,et al. Association between glutathione peroxidase 1 codon 198 variant and the occurrence of breast cancer in Rwanda , 2018, Molecular genetics & genomic medicine.
[26] M. Mzibri,et al. CHEK2 Germ Line Mutations are Lacking among Familial and Sporadic Breast Cancer Patients in Rwanda , 2018, Asian Pacific journal of cancer prevention : APJCP.
[27] C. Vachon,et al. Common Genetic Variation and Breast Cancer Risk—Past, Present, and Future , 2018, Cancer Epidemiology, Biomarkers & Prevention.
[28] Y. Bakri,et al. Association of p53 Codon 72 Polymorphism with Breast Cancer in a Rwandese Population , 2017, Pathobiology.
[29] J. Tsoka-Gwegweni,et al. Breast cancer among women in sub-Saharan Africa: prevalence and a situational analysis , 2017 .
[30] K. Lukong,et al. Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants , 2017, Breast Cancer Research and Treatment.
[31] W. Chung,et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers , 2017, JAMA.
[32] Lara E Sucheston-Campbell,et al. Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry , 2017, Cancer Epidemiology, Biomarkers & Prevention.
[33] Lara E Sucheston-Campbell,et al. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer. , 2016, Human molecular genetics.
[34] Sheena M. Scroggins,et al. Improving performance of multigene panels for genomic analysis of cancer predisposition , 2016, Genetics in Medicine.
[35] A. Vral,et al. BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer , 2015, BMC Cancer.
[36] S. West,et al. Structure and Mechanism of Action of the BRCA2 Breast Cancer Tumor Suppressor , 2014, Nature Structural &Molecular Biology.
[37] E. van Limbergen,et al. From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo , 2014, BMC Public Health.
[38] Richard J. K. Taylor,et al. A review of life expectancy and infant mortality estimations for Australian Aboriginal people , 2014, BMC Public Health.
[39] K. Nathanson,et al. Common breast cancer risk variants in the post-COGS era: a comprehensive review , 2013, Breast Cancer Research.
[40] O. Olopade,et al. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients , 2012, International journal of cancer.
[41] M. C. Leske,et al. Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry , 2012, Breast Cancer Research and Treatment.
[42] W. Foulkes,et al. A founder BRCA2 mutation in non‐Afrikaner breast cancer patients of the Western Cape of South Africa , 2012, Clinical genetics.
[43] O. Díez,et al. Novel BRCA1 deleterious mutation (c.1949_1950delTA) in a woman of Senegalese descent with triple-negative early-onset breast cancer. , 2011, Oncology letters.
[44] J. Witte,et al. Validation of Genome-Wide Prostate Cancer Associations in Men of African Descent , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[45] C. Rotimi,et al. Transferability and Fine-Mapping of Genome-Wide Associated Loci for Adult Height across Human Populations , 2009, PloS one.
[46] L. Kuller,et al. Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study , 2009, Infectious Agents and Cancer.
[47] L. Kuller,et al. Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: A case control study , 2008, BMC Cancer.
[48] N. Rahman,et al. ATM and breast cancer susceptibility , 2006, Oncogene.
[49] H. Arksey,et al. Scoping studies: towards a methodological framework , 2005 .
[50] V. Beral,et al. Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans , 2002, British Journal of Cancer.
[51] C. Adebamowo,et al. Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer , 2000, Human Genetics.
[52] C. Deng,et al. Roles of BRCA1 and its interacting proteins , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[53] Olufunmilayo I. Olopade,et al. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer , 2000, Human Genetics.
[54] D E Weeks,et al. Polygenic disease: methods for mapping complex disease traits. , 1995, Trends in genetics : TIG.
[55] C. Adebamowo,et al. Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry , 2008, Familial Cancer.